Dolin v. GSK

|

(7th Circuit,filed January 29, 2018): Arguing that the Court should reject the theory of innovator liability.

Court ruled in favor of ATRA's position

On August 22, 2018, the 7th Circuit ruled that federal law preempted the plaintiff’s claim. GSK was barred from adding a warning about the risk of suicide. The court did not rule regarding innovator liability. 

Latest News

View all news

SCOTUS Should Affirm Federal Law Supremacy With FDA Authority Case

The U.S. Supreme Court has a chance to rein in state court rulings that impose liability on pharmaceutical companies that go beyond, and even contradict, the federal regulatory process of the FDA, according to Tiger Joyce, president of the American Tort Reform Association. He explains why it is imperative the high court review a case involving Janssen Pharmaceuticals.